This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Philip Marsden is a panelist during the session titled “Excessive prices in pharmaceutical markets.”
For more information on this event, click here.
“We are thrilled to welcome Josh back to our team,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “Josh’s deep expertise...
In the article, “Residual Doubts: Carving Up Common Impact in the Turkey Class Certification Decision,” published by the American Bar Association (ABA), CRA’s...
The conference highlights new research relating to intellectual property, the economics of innovation, technology commercialization and litigation. IP Day...
Oli Latham is a panelist during the session discussing “Power, AI and Ecosystems.” For more information on this event, click here.
